Medibank Private Ltd shares could run higher

Health insurers Medibank Private Ltd (ASX:MPL) and NIB Holdings Ltd (ASX:NHF) will have new problems to tackle in the future.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Australia's biggest insurer, Medibank Private Ltd (ASX: MPL) has seen its share price soar recently after successful cost cutting resulted in a big leap in profits – and today's prices suggest investors are expecting more where that came from.

But how much more is there to cut?

Medibank reported that in the 2014-2015 financial year, it paid out $5.1 billion in claims. $3.47 billion (68%) of this went on hospital admissions and procedures, while a further $480 million (14%) went on prosthetics.

The company has already made headlines for putting the squeeze on hospital operators (who Medibank reimburses for their services), effectively demanding improved terms. Prosthetic device sellers like Lifehealthcare Group Ltd (ASX: LHC) and Paragon Care Ltd. (ASX: PGC) may also come under pressure, as the cost of fitting these devices is reportedly exorbitant.

The next step may be to target customers, since Medibank claims on its website that one in five Australians lives with two or more chronic conditions. The most common conditions are diabetes, heart disease, cancer, mental health, eye disease, respiratory conditions, and arthritis.

An egalitarian healthcare system

Passing on costs will be difficult, since Medibank has publicly affirmed its commitment to an equal health insurance system – where each customer pays the same premiums regardless of their level of health and wellbeing.

Here is a picture of the most prevalent conditions, according to Medibank:

source: Medibank.com.au
source: Medibank.com.au

In one sense, Australians are fortunate that the procedures requiring more resource-intensive treatments like cancer and cardiovascular disease are comparatively less prevalent, as this limits the burden on the healthcare system.

However, the prevalence of 'lifestyle' conditions such as poor diet and obesity – which can lead to cardiovascular disease and diabetes among others – is rising.

Additionally, my own experience studying psychology suggests that mental health conditions are significantly under-treated. This could be a potential source of rising claims costs in coming years.

Insurers like Medibank and NIB Holdings Limited (ASX: NHF) attempt to target lifestyle conditions by offering incentives like discounted gym memberships and similar, although it's an open question whether free gym memberships will have a significant correlation with a reduction in lifestyle diseases.

Medibank has reported in the past that a minority of clients account for a significant percentage of its expenses, and with the health system also an enormous burden on the national budget, the logical next step may be to attempt to recover some costs from consumers. There are a variety of alternatives for cutting costs, including the following proposals previously put forward by Medibank.

Lower costs don't have to result in the cessation of services like the recently announced government cuts to pathology services. Instead, it could take the form of an additional percentage-based fee on top of ordinary premiums for individuals who fail to meet certain scientifically justified 'wellness' criteria. The advent of wearable technology is likely to make the implementation of this substantially easier in coming years.

Food for thought if you're a shareholder – or feeling the sting of higher premiums in recent years.

Motley Fool contributor Sean O'Neill has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »